Myelomonocytic leukemia

In the cure of cancer, a major cause of today's mortality, chemotherapy is the most common treatment, though serious frequent… Expand

Despite the recent identification of recurrent SETBP1 mutations in atypical chronic myeloid leukemia (aCML), a complete… Expand

TET2 enzymatically converts 5-methyl-cytosine to 5-hydroxymethyl-cytosine, possibly leading to loss of DNA methylation. TET2… Expand

Myeloproliferative neoplasms are frequently associated with aberrant constitutive tyrosine kinase (TK) activity resulting from… Expand

We analyzed the expression of the inhibitor of apoptosis survivin by immunocytochemistry in bone marrow cells from patients with… Expand

Some regulators of plant growth and differentiation have been shown to induce the differentiation of several human myeloid… Expand

Huntingtin-interacting protein 1 (HIP1) interacts with huntingtin, the protein whose gene is mutated in Huntington's disease. In… Expand

The activities of protein tyrosine kinase and phosphatidylinositol turnover have been found to be associated with cell growth and… Expand

We report the case of a patient with scleromyxedema with abnormal monoclonal gamma globulin of the kappa type who was treated… Expand

Regulation of the growth and production of granulocyte colony-stimulating activity (CSA) by WEHI-3 cells, a lysozyme-secreting… Expand